UNeMed Corporation is a tech transfer and commercialization company affiliated with the University of Nebraska Medical Center and the University of Nebraska at Omaha. Founded in 1991, the company has built a diverse portfolio of intellectual property in the biotechnology and health care sectors, showcasing significant advances in biomedical and clinical technology. UNeMed focuses on facilitating the transfer of new technology and inventions from academic laboratories to the marketplace, providing technology development and commercialization services for both the University of Nebraska Medical Center and the University of Nebraska at Omaha. UNeMed distinguishes itself through a customized partnering approach, tailored to meet the unique needs of each partner and partnership. The company acts as a bridge, connecting industry partners with university researchers to develop new products, solve research problems, and link entrepreneurs and investors with cutting-edge technologies with startup potential. They also match researchers with industry partners to facilitate technology commercialization, providing ongoing support to ensure the realization of results. With a team of experts, UNeMed focuses on bringing high-quality ideas, innovative products, and elegant solutions from academic research to meet the needs of their clients. They invite potential partners to connect with them to explore the benefits of collaborating with UNeMed. Operating from the United States, UNeMed Corporation represents a valuable opportunity for investors seeking to engage with innovative advancements in the biotechnology and health care industries.
There is no investment information
No recent news or press coverage available for UNeMed Corporation.